Synapse

← Expert Review of Precision Medicine and Drug Development

Papers in Expert Review of Precision Medicine and Drug Development

Page 2 · newest first

  1. Using quantitative computed tomography to predict mortality in patients with interstitial lung disease related to systemic sclerosis: implications for personalized medicineExpert Review of Precision Medicine and Drug Development · 2020
  2. The evolution of patient-specific precision biomarkers to guide personalized heart-transplant careExpert Review of Precision Medicine and Drug Development · 2020
  3. Toll-like receptor immune modulatory role in personalized management of colorectal cancer, review of literatureExpert Review of Precision Medicine and Drug Development · 2020
  4. Enasidenib for the treatment of relapsed or refractory acute myeloid leukemia with an isocitrate dehydrogenase 2 mutationExpert Review of Precision Medicine and Drug Development · 2020
  5. Personalized asthma management in pediatric patients based on treatment responseExpert Review of Precision Medicine and Drug Development · 2020
  6. Predicting therapy response by analysis of metastasis founder cells: emerging perspectives for personalized tumor therapyExpert Review of Precision Medicine and Drug Development · 2020
  7. Formulation, manufacturing and regulatory strategies for extracellular vesicles-based drug products for targeted therapy of central nervous system diseasesExpert Review of Precision Medicine and Drug Development · 2020
  8. Utilizing biomarkers associated with cardiovascular events in atrial fibrillation: informing a precision medicine responseExpert Review of Precision Medicine and Drug Development · 2020
  9. Noninvasive biomarkers to guide intervention: toward personalized patient management in prostate cancerENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) · 2020
  10. Pharmacogenetic and pharmaco-miR biomarkers for tailoring and monitoring myasthenia gravis treatmentsExpert Review of Precision Medicine and Drug Development · 2020
  11. Genomic-based treatment of patients with head and neck cancerExpert Review of Precision Medicine and Drug Development · 2020
  12. A wide perspective of targeted therapies for precision medicine in autoimmune diseasesExpert Review of Precision Medicine and Drug Development · 2020
  13. An overview on precision therapy in bladder cancerExpert Review of Precision Medicine and Drug Development · 2020
  14. Roles of CRAC channel in cancer: implications for therapeutic developmentExpert Review of Precision Medicine and Drug Development · 2020
  15. Ivosidenib for the treatment of relapsed or refractory acute myeloid leukemia with an IDH1 mutationExpert Review of Precision Medicine and Drug Development · 2020
  16. Deep sequencing as an approach to understanding the complexity and improving the treatment of multiple myelomaExpert Review of Precision Medicine and Drug Development · 2020
  17. Multi-dimensional COVID-19 short- and long-term outcome prediction algorithmExpert Review of Precision Medicine and Drug Development · 2020
  18. The pharmacogenetics of tacrolimus and its implications for personalized therapy in kidney transplant recipientsExpert Review of Precision Medicine and Drug Development · 2020
  19. The emerging role of precision medicine in the treatment of ovarian cancerExpert Review of Precision Medicine and Drug Development · 2020
  20. The outlook for precision medicine for the treatment of chronic hepatitis C infection: challenges and opportunitiesExpert Review of Precision Medicine and Drug Development · 2020
  21. Phenotyping severe asthma: a rationale for biologic therapyExpert Review of Precision Medicine and Drug Development · 2020
  22. Prognostic models to help predict patient responses to intravesical immunotherapyExpert Review of Precision Medicine and Drug Development · 2020
  23. Pharmacogenetic considerations in antiplatelet therapyExpert Review of Precision Medicine and Drug Development · 2020
  24. Emerging precision therapies for gastric cancerExpert Review of Precision Medicine and Drug Development · 2020
  25. Personalized approaches for the management of glaucomaExpert Review of Precision Medicine and Drug Development · 2020
  26. How can bioinformatics contribute to the routine application of personalized precision medicine?Expert Review of Precision Medicine and Drug Development · 2020
  27. Precision medicine in cardiac electrophysiology: where we are and where we need to goExpert Review of Precision Medicine and Drug Development · 2020
  28. Genetic background of coronary artery disease: clinical implications and perspectivesExpert Review of Precision Medicine and Drug Development · 2020
  29. Pharmacogenomics of drugs used to treat brain disordersExpert Review of Precision Medicine and Drug Development · 2020
  30. Toward gene therapy in rheumatoid arthritisExpert Review of Precision Medicine and Drug Development · 2020
  31. Artificial intelligence-enabled electrocardiogram: can we identify patients with unrecognized atrial fibrillation?Expert Review of Precision Medicine and Drug Development · 2020
  32. A meta-analysis on diagnostic accuracy of serum HLA-G level in breast cancerExpert Review of Precision Medicine and Drug Development · 2020
  33. Genomic sequencing in severe epilepsy: a step closer to precision medicineExpert Review of Precision Medicine and Drug Development · 2020
  34. Proteomics-inspired precision medicine for treating and understanding multiple myelomaExpert Review of Precision Medicine and Drug Development · 2020
  35. Nab-paclitaxel and atezolizumab for the treatment of PD-L1-positive, metastatic triple-negative breast cancer: review and future directionsExpert Review of Precision Medicine and Drug Development · 2020
  36. Moving beyond endocrine therapy for luminal metastatic breast cancer in the precision medicine era: looking for new targetsExpert Review of Precision Medicine and Drug Development · 2020
  37. Challenges and advances in translating gene therapy for hearing disordersExpert Review of Precision Medicine and Drug Development · 2020
  38. Predicting therapeutic response through biomarker analysis in psoriatic arthritis, an example of precision medicineExpert Review of Precision Medicine and Drug Development · 2020
  39. On the path toward personalized medicine: implications of pharmacogenetic studies of alcohol use disorder medicationsExpert Review of Precision Medicine and Drug Development · 2020
  40. Patient-derived organoid analysis of drug resistance in precision medicine: is there a value?Expert Review of Precision Medicine and Drug Development · 2020
  41. How clinical biobanks can support precision medicine: from standardized preprocessing to treatment guidanceExpert Review of Precision Medicine and Drug Development · 2019
  42. How does race and ethnicity effect the precision treatment of asthma?Expert Review of Precision Medicine and Drug Development · 2019
  43. Sickle cell disease in the era of precision medicine: looking to the futureExpert Review of Precision Medicine and Drug Development · 2019
  44. Using organoid models to predict chemotherapy efficacy: the future of precision oncology?Expert Review of Precision Medicine and Drug Development · 2019
  45. Cardiac imaging and circulating biomarkers for primary prevention in the era of precision medicineExpert Review of Precision Medicine and Drug Development · 2019
  46. Gene therapy trials for haemophilia: a step closer to a cure?Expert Review of Precision Medicine and Drug Development · 2019
  47. Using metabolomics to develop precision medicine strategies to treat nonalcoholic steatohepatitisExpert Review of Precision Medicine and Drug Development · 2019
  48. Personalized therapies for the treatment of allergic rhinitisExpert Review of Precision Medicine and Drug Development · 2019
  49. Precision medicine for TP53-mutated acute myeloid leukemiaExpert Review of Precision Medicine and Drug Development · 2019
  50. Human regulatory T cells (Treg) and their response to cancerExpert Review of Precision Medicine and Drug Development · 2019